ZITSTICKA KILLA ACNE EXTRA STRENGTH- salicylic acid patch

Zitsticka Killa Acne Extra Strength by

Drug Labeling and Warnings

Zitsticka Killa Acne Extra Strength by is a Otc medication manufactured, distributed, or labeled by Brndxl LLC, BRNDXL LLC, Raphas Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

INACTIVE INGREDIENT

Sodium Hyaluonate, Phytosphingosine HCL, Niacinamide, Oligopeptide-10, Glycolic Acid, Madecassoside, 4-Butyl-Resorcinol

WARNINGS

For external use only

ACTIVE INGREDIENT

Salicylic Acid 2%

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

PURPOSE

Acne Treatment

INDICATIONS & USAGE

• For the management of acne.
• Penetrates pores to eliminate most blemishes.

DOSAGE & ADMINISTRATION

1. Swipe target area with included CLEANA swab.
2. Once dry, apply KILLA ACNE Extra Strength pimple patch onto zit.
3. Leave on for 2+ hrs for microdarts to dissolve (for best results, leave on overnight).

Zitsticka Killa Acne Extra Strength 4pk & 20pk

INGREDIENTS AND APPEARANCE

ZITSTICKA KILLA ACNE EXTRA STRENGTH 
salicylic acid patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 83742-444
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	2 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
GLYCOLIC ACID (UNII: 0WT12SX38S)
NIACINAMIDE (UNII: 25X51I8RD4)
MADECASSOSIDE (UNII: CQ2F5O6YIY)
SODIUM HYALURONATE (UNII: YSE9PPT4TH)
4-BUTYLRESORCINOL (UNII: 2IK4UQ3ZGA)
OLIGOPEPTIDE-10 (UNII: Q46328TRNK)
PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83742-444-04	4 in 1 BOX	12/01/2025
1		1 g in 1 PATCH; Type 0: Not a Combination Product
2	NDC: 83742-444-20	20 in 1 BOX	12/01/2025
2		1 g in 1 PATCH; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	12/01/2025

Labeler - Brndxl LLC (119111890)

Registrant - BRNDXL LLC (119111890)

Establishment
Name	Address	ID/FEI	Business Operations
Raphas Co., Ltd		695914964	manufacture(83742-444)